Julian A. Gatta

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for <i>Burkholderia cepacia</i> Complex Isolates from Cystic Fibrosis Patients

Krisztina M. Papp‐Wallace, Scott A. Becka, Elise T. Zeiser et al. · ACS Infectious Diseases · 2017 · 75 citations · Full text

Evaluation of a Commercial Microarray System for Detection of SHV-, TEM-, CTX-M-, and KPC-Type β-Lactamase Genes in Gram-Negative Isolates

Andrea Endimiani, Andrea M. Hujer, Kristine M. Hujer et al. · Journal of Clinical Microbiology · 2010 · 65 citations · Full text

Insights into β-Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance Determinants

Krisztina M. Papp‐Wallace, Magdalena A. Taracila, Julian A. Gatta et al. · Journal of Biological Chemistry · 2013 · 55 citations · Full text

Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases

Krisztina M. Papp‐Wallace, Saralee Bajaksouzian, Ayman M. Abdelhamed et al. · Diagnostic Microbiology and Infectious Disease · 2015 · 40 citations · Full text

Antimicrobial Susceptibility, Antibiotics, Single β-Lactamases +8

Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3

Krisztina M. Papp‐Wallace, Baui Senkfor, Julian A. Gatta et al. · Antimicrobial Agents and Chemotherapy · 2012 · 40 citations · Full text